AUSTIN — Attorney General Ken Paxton sued major pharmaceutical makers and other companies Thursday, alleging they violated ...

In a phase 3 trial, tolebrutinib has a significant effect on slowing disability progression in some patients with multiple sclerosis..

By Sandra Agyeiwaa OTOO The Ghana Heart Initiative (GHI) that was established in January 2019 has successfully ended, paving the way for the AYA-Integrated Healthcare Initiative launch. This ...

With a presence in 28 countries, this acquisition further strengthens its position as the leading pan-African distributor of pharmaceutical products ...

The WHO has recommended a single shot of RSV vaccine for pregnant women, in the third trimester that typically starts at 28 weeks, to protect their babies.

The company entered the OTC business in 2007 and it has grown to have established brands such as Manforce, HealthOK, Prega ...

The label expansion provides a new option for the hundreds of thousands of Americans with inadequately controlled COPD.

The Digital Markets, Competition and Consumers Act 2024 (UK DMCC) introduces significant reforms to the UK’s Competition and Markets Authority ...

The announcements by Cigna, CVS, Humana, Centene, and UnitedHealth were made ahead of the beginning of Medicare Advantage enrollment, which begins Oct. 15. Among other news, a top California health ...

Sanofi has asked bidders to revise their proposals for its consumer health unit, people with knowledge of the matter said, as ...

Plus, news about IN8bio, Sanofi, Vicore Pharma, Cartherics, Zephyrm Bioscience, Tharimmune and Intract Pharma: Biohaven’s $250M offering: The move comes after Biohaven announced Monday that it started ...

EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has today announced the appointment of Dr. Daniel Von Hoff to ...